News and Announcements
OncoSil Appoints Independent Non-Executive Director
- Published January 21, 2016 10:19AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st January 2016, ASX Announcement
OncoSil Medical Limited (ASX: OSL) is pleased to announce the appointment today of Dr Chris Roberts as an Independent Non-Executive Director of the Company, with immediate effect.
Dr Robert is a highly experienced director and senior executive with 40 years’ experience in the medical innovation space. During this time he has served on the boards of a number of ASX listed companies as well as research institutions and government entities.
Dr Roberts has forged a long and successful career in the medical device sector. He was Chief Executive Officer/President of Cochlear Limited (ASX: COH) from February 2004 to August 2015. Cochlear is the global market leader in inplantable devices, such as cochlear implants, for the hearing impaired. Dr Roberts was primarily responsible for the significant increase in the Cochlear Limited’s sales from $348m in 2005 to $926m in 2015.
To read the full announcement, please click here.